CD8A and metabolic dysfunction-associated steatohepatitis: Still, a current study found that increased cDC1 of the DC subtype may promote CD8+ T cells, which can promote liver inflammation and injury in NASH, suggesting that cDC1 is a participant in the pathogenesis of NASH (95).